These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8960364)

  • 41. Regulation of J6 gene expression by transcription factor GATA-4.
    Bielinska M; Wilson DB
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):183-9. PubMed ID: 7717974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Control of beta-interferon expression in murine embryonal carcinoma F9 cells.
    Francis MK; Lehman JM
    Mol Cell Biol; 1989 Aug; 9(8):3553-6. PubMed ID: 2796997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells.
    Stoner CM; Gudas LJ
    Cancer Res; 1989 Mar; 49(6):1497-504. PubMed ID: 2538228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression pattern of Oct-4 in preimplantation embryos of different species.
    Kirchhof N; Carnwath JW; Lemme E; Anastassiadis K; Schöler H; Niemann H
    Biol Reprod; 2000 Dec; 63(6):1698-705. PubMed ID: 11090438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.
    de Groot RP; Schoorlemmer J; van Genesen ST; Kruijer W
    Nucleic Acids Res; 1990 Jun; 18(11):3195-202. PubMed ID: 2113273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells.
    Okuda A; Fukushima A; Nishimoto M; Orimo A; Yamagishi T; Nabeshima Y; Kuro-o M; Nabeshima Yi; Boon K; Keaveney M; Stunnenberg HG; Muramatsu M
    EMBO J; 1998 Apr; 17(7):2019-32. PubMed ID: 9524124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered DNA/protein complexes specific for the beta-interferon regulatory region observed in murine embryonal carcinoma F9 cells.
    Francis MK; Lehman JM
    J Cell Biochem; 1992 Aug; 49(4):366-77. PubMed ID: 1429865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of nuclear lamins A/C during in vitro-induced differentiation of F9 and P19 embryonal carcinoma cells.
    Mattia E; Hoff WD; den Blaauwen J; Meijne AM; Stuurman N; van Renswoude J
    Exp Cell Res; 1992 Dec; 203(2):449-55. PubMed ID: 1281113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Receptor-selective retinoids implicate retinoic acid receptor alpha and gamma in the regulation of bmp-2 and bmp-4 in F9 embryonal carcinoma cells.
    Rogers MB
    Cell Growth Differ; 1996 Jan; 7(1):115-22. PubMed ID: 8788040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells.
    Yeom YI; Fuhrmann G; Ovitt CE; Brehm A; Ohbo K; Gross M; Hübner K; Schöler HR
    Development; 1996 Mar; 122(3):881-94. PubMed ID: 8631266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A putative G-protein-coupled receptor, H218, is down-regulated during the retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
    Li Y; MacLennan AJ; Rogers MB
    Exp Cell Res; 1998 Mar; 239(2):320-5. PubMed ID: 9521849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulated expression of Krox-24 and other serum-responsive genes during differentiation of P19 embryonal carcinoma cells.
    Lanoix J; Belhumeur P; Lussier M; Royal A; Bravo R; Skup D
    Cell Growth Differ; 1991 Aug; 2(8):391-9. PubMed ID: 1793734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo.
    Minucci S; Botquin V; Yeom YI; Dey A; Sylvester I; Zand DJ; Ohbo K; Ozato K; Scholer HR
    EMBO J; 1996 Feb; 15(4):888-99. PubMed ID: 8631309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicomponent differentiation-regulated transcription factors in F9 embryonal carcinoma stem cells.
    Shivji MK; La Thangue NB
    Mol Cell Biol; 1991 Mar; 11(3):1686-95. PubMed ID: 1825349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types.
    Nakhei H; Lingott A; Lemm I; Ryffel GU
    Nucleic Acids Res; 1998 Jan; 26(2):497-504. PubMed ID: 9421506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression of the Oct-2 protein during cell differentiation in vivo and in vitro].
    Pankratova EV; Sytina EV; Stepchenko AG
    Mol Biol (Mosk); 1993; 27(4):817-26. PubMed ID: 8361489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Constitutive expression of the Wilms tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid.
    Kudoh T; Ishidate T; Nakamura T; Toyoshima K; Akiyama T
    Oncogene; 1996 Oct; 13(7):1431-9. PubMed ID: 8875981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SC1 inhibits the differentiation of F9 embryonic carcinoma cells induced by retinoic acid.
    Liu Y; Ren X; Ke J; Zhang Y; Wei Q; Shi Z; Ai Z; Guo Z
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):793-799. PubMed ID: 29945210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.